Suppr超能文献

甲状腺激素敏感性受损与慢性肾脏病患者的全因死亡率和特定病因死亡率相关:来自2007 - 2012年美国国家健康与营养检查调查(NHANES)的结果。

Impaired sensitivity to thyroid hormones is associated with all-cause and cause-specific mortality among chronic kidney disease patients: results from National Health and Nutrition Examination Survey (NHANES) 2007-2012.

作者信息

Liu Chan, Zhu Xiaoxiao, Wang Dingding, Huang Naya, Chen Wei

机构信息

Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health of China, Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China.

Department of General Practice, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Ren Fail. 2024 Dec;46(2):2433178. doi: 10.1080/0886022X.2024.2433178. Epub 2024 Dec 17.

Abstract

BACKGROUND

Resistance to thyroid hormone shows underlying mechanical link with chronic kidney disease (CKD) and is prevalent in CKD population. However, whether it attributes to mortality risk among CKD population is unknown. This study aimed to examine the association of thyroid hormone resistance (THR) with all-cause and cause-specific mortality among CKD individuals.

METHODS

This study extracted CKD population from the National Health and Nutrition Examination Survey (NHANES) 2007-2012. Death outcomes were ascertained by linkage to National Death Index records through 31 December 2019. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence interval (CI) for mortality from all causes, cardiovascular disease (CVD).

RESULTS

A total of 1,634 adults with CKD were included in the cohort, in which 663 deaths were recorded during an average follow-up of 8.72 years. After multivariate adjustment, resistance to thyroid hormone was significantly associated with higher all-cause and CVD mortality. There was an 18% and 31% increase in risks of all-cause and CVD mortality per-standard deviation (SD) increment in Parametric Thyroid Feedback Quantile-based Index (PTFQI) respectively. When PTFQI was analyzed as categorical variable (classified according to PTFQI percentiles), after adjusted for potential confounders and taking PTFQI ≤ as reference, the HRs and 95% CIs in category with PTFQI > for all-cause mortality and CVD mortality were 2.12 [1.10, 4.09] ( for trend 0.026) and 5.14 [1.81, 14.60] for ( for trend 0.018), respectively.

CONCLUSIONS

Resistance to thyroid hormone, centered on variations in the typical pituitary response to thyroid hormones, may independently correlate with all-cause and CVD mortality in CKD patients.

摘要

背景

甲状腺激素抵抗与慢性肾脏病(CKD)存在潜在的机制联系,且在CKD人群中普遍存在。然而,其是否归因于CKD人群的死亡风险尚不清楚。本研究旨在探讨甲状腺激素抵抗(THR)与CKD个体全因死亡率和特定病因死亡率之间的关联。

方法

本研究从2007 - 2012年美国国家健康与营养检查调查(NHANES)中提取CKD人群。通过与截至2019年12月31日的国家死亡指数记录进行关联来确定死亡结局。采用Cox比例风险模型估计全因死亡率、心血管疾病(CVD)死亡率的风险比(HRs)和95%置信区间(CI)。

结果

该队列共纳入1634例成年CKD患者,平均随访8.72年期间记录到663例死亡。多因素调整后,甲状腺激素抵抗与较高的全因死亡率和CVD死亡率显著相关。基于参数化甲状腺反馈分位数指数(PTFQI)每增加一个标准差(SD),全因死亡率和CVD死亡率风险分别增加18%和31%。当将PTFQI作为分类变量分析时(根据PTFQI百分位数分类),在调整潜在混杂因素后,以PTFQI≤ 为参照,PTFQI> 类别中全因死亡率和CVD死亡率的HRs及95%CI分别为2.12 [1.10, 4.09](趋势 0.026)和5.14 [1.81, 14.60](趋势 0.018)。

结论

以垂体对甲状腺激素的典型反应变化为中心的甲状腺激素抵抗,可能与CKD患者的全因死亡率和CVD死亡率独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d4/11654039/fa190e31ba68/IRNF_A_2433178_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验